Safety and Tolerability of Ubrogepant Following Intermittent, High-Frequency Dosing
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cephalalgia: An International Journal of Headache
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Tolerability of Ubrogepant Following Intermittent, High-Frequency Dosing: Randomized, Placebo-Controlled Trial in Healthy Adults
Cephalalgia 2019 Sep 19;[EPub Ahead of Print], PJ Goadsby, SJ Tepper, PB Watkins, G Ayele, R Miceli, M Butler, L Severt, M Finnegan, A Szegedi, JM Trugman, A JakateFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.